ADAPTIVE BIOTECHNOLOGIES
Adaptive Biotechnologies is in a category of one. They have mapped T-cell receptors to specific antigens to read the record stored in the body’s adaptive immune system. Their breakthrough combines a decade of biological research with computational advances in machine learning.
Our job was to simultaneously promote the first-ever crowd sourced COVID-19 research study, launch their first consumer product called T-Detect for COVID-19, and develop a new brand story and identity for HCP, investor and consumer audiences. Below is a sample of that work, including social recruitment for the COVID-19 study, and the website we created to launch their brand.
Motion graphic animation from the social campaign to recruit participants for the first-ever crowd sourced COVID-19 study.
The social campaign was promoted on Facebook, Instagram and Instagram Stories.
The portraits were both appropriate in tone for the height of the COVID-19 pandemic, inspirational in resolve, and diverse in representation. We were able to fill the study in two weeks.
The website launch included a new logo, visual identity and brand story that clearly presented and articulated Adaptive’s breakthrough, vision and clinical applications. Adaptive had the second most successful IPO of 2019, and the website had to clearly articulate the brands proposition to HCPs, investors and consumers. The website also serves as a recruitment tool to attract the brightest minds.
Click on an image to launch the website in a new window.
